Literature DB >> 6374280

Nifedipine: kinetics and dynamics after single oral doses.

H R Ochs, K D Rämsch, B Verburg-Ochs, D J Greenblatt, J Gerloff.   

Abstract

Serum nifedipine concentrations and hemodynamic changes were evaluated in ten healthy volunteers after a single 40-mg oral dose of nifedipine. Peak serum concentrations averaged 45 micrograms/l, attained 2.7 h after dosage. The mean elimination half-life was 5.9 h (range: 3-12 h). Blood pressure, ventricular rate, and echocardiographically-determined rate of circumferential fiber shortening did not differ between placebo and nifedipine trials. Five additional subjects ingested nifedipine once in the control state and on a second occasion with a standard breakfast. Coingestion of food delayed the peak serum nifedipine concentration but did not alter the area under the serum concentration curve. Thus the pharmacokinetic profile of nifedipine indicates that a three- or four-times-daily dose is, in general, appropriate in clinical practice. Completeness of absorption is not altered by coadministration with food. Adverse hemodynamic effects of single oral doses in healthy persons are not evident.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6374280     DOI: 10.1007/bf01742301

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  5 in total

1.  Gas chromatographic determination of nifedipine and one of its metabolites using electron capture detection.

Authors:  P Jakobsen; O Lederballe Pedersen; E Mikkelsen
Journal:  J Chromatogr       Date:  1979-01-01

2.  Calcium-channel blockers: pharmacologic considerations.

Authors:  E Braunwald
Journal:  Am Heart J       Date:  1982-09       Impact factor: 4.749

3.  [Hemodynamic and coronary effect of various calcium antagonists under rest conditions].

Authors:  W Jansen; M Tauchert; V Hombach; B Niehues; D W Behrenbeck; H H Hilger
Journal:  Med Welt       Date:  1983-03-04

4.  Intravenous quinidine: pharmacokinetic properties and effects on left ventricular performance in humans.

Authors:  H R Ochs; E Grube; D J Greenblatt; E Woo; G Bodem
Journal:  Am Heart J       Date:  1980-04       Impact factor: 4.749

5.  Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects.

Authors:  T S Foster; S R Hamann; V R Richards; P J Bryant; D A Graves; R G McAllister
Journal:  J Clin Pharmacol       Date:  1983-04       Impact factor: 3.126

  5 in total
  8 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Pharmacokinetics of nifedipine derived from a new retard tablet formulation.

Authors:  A Avgerinos; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Oct-Dec       Impact factor: 2.441

Review 3.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

4.  The influence of food on the pharmacokinetics of 'biphasic' nifedipine at steady state in normal subjects.

Authors:  G H Rimoy; J R Idle; N K Bhaskar; P C Rubin
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

5.  The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine.

Authors:  V Challenor; D G Waller; B S Gruchy; A G Renwick; C F George; E T McMurdo; J McEwen
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

6.  Food and nifedipine pharmacokinetics.

Authors:  V F Challenor; D G Waller; B S Gruchy; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

7.  Dose response and length of action of nifedipine capsules and tablets in patients with essential hypertension: a randomised crossover study.

Authors:  F P Cappuccio; N D Markandu; F A Tucker; G A MacGregor
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Physicochemical properties of dietary phytochemicals can predict their passive absorption in the human small intestine.

Authors:  Sophie N B Selby-Pham; Rosalind B Miller; Kate Howell; Frank Dunshea; Louise E Bennett
Journal:  Sci Rep       Date:  2017-05-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.